Chemical Compound
Pravastatin Sodium; sodium (+)-(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(S)-2-methylbutyryloxy]-1,2,6,7,8,8a-hexahydro-1-naphthyl]heptanoate; Eptastatin sodium; (betaR,deltaR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-beta,delta,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoic acid monosodium salt; 3beta-Hydroxycompactin sodium salt
CAS Registry Number
81131-70-6
Primary record
Pravastatin Sodium; sodium (+)-(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(S)-2-methylbutyryloxy]-1,2,6,7,8,8a-hexahydro-1-naphthyl]heptanoate; Eptastatin sodium; (betaR,deltaR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-beta,delta,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoic acid monosodium salt; 3beta-Hydroxycompactin sodium salt
- 库存
- 2,323 克
- 纯度
- 98.1 %
- CAS
- 81131-70-6
化合物标识与属性
- CAS
- 81131-70-6
- PubChem CID
- 16759173
- SMILES
- CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)[O-])O)O)O.[Na+]
- Canonical SMILES
- CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)[O-])[C@H]21.[Na+]
名称与同义词
- PRAVASTATIN SODIUM
- Pravachol
- Pravaselect
- Mevalotin
- Selektine
- Lipostat
- Elisor
- pravastatin
- Liprevil
- 81131-70-6
- Bristacol
- Prareduct
- Pravasine
- Aplactin
- Pralidon
- Pravacol
- Pravasin
- Sanaprav
- Selipran
- Lipemol
- Lipidal
- Eptastatin sodium
- Vasen
- Epastatin sodium
- Selectin
- Pravastatin Sodium Salt
- Dehypotin protect
- Pravastatinum
- Pravastatina
- Pravastatine
- Pravatatin
- Kopostat
- Pravigard PAC
- Liplat
- Vasten
- pravastatinsodium
- Mixture Name
- Ascarite II
- CRES Pravastatin
- Pravastatin (sodium)
- Pravachol (TN)
- Pravastatin, Sodium Salt
- CS-514
- Pravastatine [French]
- Pravastatinum [Latin]
- Pravastatina [Spanish]
- C23H35NaO7
- RefChem:56364
- 3beta-Hydroxycompactin, Na
- Pravastatin [INN:BAN]
- Pravastatin Natrium Mayrho Fer
- Sodium Salt, Pravastatin
- UNII-KXO2KT9N0G
- DTXSID6047525
- CHEMBL690
- SCHEMBL3013
- CHEBI:8361
- MFCD00887601
- Pravastatin sodium [USAN:JAN]
- DTXCID4027525
- UNII-3M8608UQ61
- 3-beta-Hydroxycompactin sodium salt
- DRG-0319
- Pravastatin (sodium) (Standard)
- Eptastatin sodium salt hydrate
- C23H35O7.Na
- Pravastatin sodium salt hydrate
- VWBQYTRBTXKKOG-IYNICTALSA-M
- CCRIS 7557
- HY-B0165AR
- orb1310398
- PRAVASTATIN SODIUM [MI]
- 3M8608UQ61
- NSC-759253
- PRAVASTATIN SODIUM [JAN]
- SQ-31000
- ERK5-3F09
- HY-B0165A
- Pravastatin sodium (JP18/USP)
- C23-H35-Na-O7
- Pravastatin sodium [USAN:USP:JAN]
- PRAVASTATIN SODIUM [USAN]
- SQ-31,000
- 81131-70-6 (sodium)
- CS514
- HMS2051P05
- HMS3268L20
- HMS3413E20
- PRAVASTATIN SODIUM [VANDF]
- SQ 31000
- PRAVASTATIN SODIUM [MART.]
- AMY40517
- C23H36O7
- CID54692
- MSK10344
- PRAVASTATIN SODIUM [USP-RS]
- PRAVASTATIN SODIUM [WHO-DD]
- Tox21_111474
- Tox21_300270
- BBF-04559
- CS 514
- EBC-11208
- s3036
- AKOS015896504
- AKOS015964902
- C23-H36-O7
- CB11211
- CCG-100926
- CS-2003
- FP27125
- NC00176
- NSC 759253
- SQ31000
- PRAVASTATIN SODIUM [ORANGE BOOK]
- NCGC00092370-01
- NCGC00095183-01
- NCGC00254232-01
- PRAVASTATIN SODIUM [EP MONOGRAPH]
- BP164292
- CPD000469187
- LS-94711
- PRAVASTATIN SODIUM [USP MONOGRAPH]
- SAM001246656
- SC-46788
- SQ31,000
- SY077493
- CAS-81131-70-6
- Pravastatin sodium salt - Bio-X trade mark
- SQ 31,000
- ST2407537
- A4369
- CS-0694887
- P1796
- A11912
- D00893
- PRAVIGARD PAC COMPONENT PRAVASTATIN SODIUM
- A840049
- I06-2463
- Q27108059
- Pravastatin sodium salt hydrate, >=98% (HPLC), powder
- sodium;(3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate
- 81093-37-0
- Sodium (+)-(betaR,deltaR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-hexahydro-beta,delta,6,8-tetrahydroxy-2-methyl-1-naphthaleneheptanoate, 8-((2S)-2-methylbutyrate)
- (3R,5R)-3,5-Dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-(((S)-2-methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoic acid, sodium salt
- (betaR,deltaR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-beta,delta,6-trihydroxy-2-methyl-8[(2S)-2-methyl-1-oxobutoxyl]-1-naphthaleneheptanoic Acid Na
- 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-2-methyl-8-(2-methyl-1-oxobutoxy)-beta,delta,6-trihydroxy-, monosodium salt, (1S-(1-alpha(beta-S*,delta-S*),2-alpha,6-alpha,8-beta(R*),8a-alpha))-
- 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, monosodium salt, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-
- 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-, sodium salt (1:1), (betaR,deltaR,1S,2S,6S,8S,8aR)-
- Pravastatin sodium, 98%, a HMG-CoA reductase inhibitor - 100mg 100mg
- sodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-(((S)-2-methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoate
- sodium (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoate
- (?-R,?R,1S,2S,6S,8S,8?R)-1,2,6,7,8,8?-Hexahydro-?,? ,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthalenehep tanoic acid sodium salt
- (?R,?R,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-?,?,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoic acid monosodium salt
- (|AR, |AR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-|A, |A,6-trihydroxy-2-methyl-8[(2S)-2-methyl-1-oxobutoxyl]-1-naphthaleneheptanoic acid sodium hydrate
- (|AR,|AR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-|A,|A,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoic Acid Sodium Salt
- (2S)-4-methyl-2-[methyl-[(2R)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]amino]pentanoic acid
- (3R,5R)-3,5-Dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-(((S)-2-methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoicacid,sodiumsalt
- 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-.beta.,.delta.,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-, monosodium salt, (.beta.R,.delta.R,1S,2S,6S,8S,8aR)-
- 1-NAPHTHALENEHEPTANOIC ACID, 1,2,6,7,8,8A-HEXAHYDRO-.BETA.,D,6-TRIHYDROXY-2-METHYL-8-(2-METHYL-1-OXOBUTOXY)-, MONOSODIUM SALT, (1S-(1.ALPHA.(.BETA.S*,DS*),2.ALPHA.,6.ALPHA.,8.BETA.(R*),8A.ALPHA.))-
- 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-|_,|_,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-, sodium salt (1:1), (|_R,|_R,1S,2S,6S,8S,8aR)-
- 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-|A,|A,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-, sodium salt (1:1), (|AR,|AR,1S,2S,6S,8S,8aR)-
- 81133-20-2
- 81135-35-5
- Monosodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-((2S)-2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoate
- Pravastatin Sodium; sodium (+)-(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(S)-2-methylbutyryloxy]-1,2,6,7,8,8a-hexahydro-1-naphthyl]heptanoate; Eptastatin sodium; (betaR,deltaR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-beta,delta,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoic acid monosodium salt; 3beta-Hydroxycompactin sodium salt
- SODIUM (+)-(.BETA.R,DR,1S,2S,6S,8S,8AR)-1,2,6,7,8,8A-HEXAHYDRO-.BETA.,D,6,8-TETRAHYDROXY-2-METHYL-1-NAPHTHALENEHEPTANOATE, 8-((2S)-2-METHYLBUTYRATE)